Generic Drug Analysis & Statistics, February 2015

24/7 Customer Support

Talk to Louis

+1 718 618 4302

All regions

1-30 of about 600 reports

Purchase Reports From Reputable Market Research Publishers

Patent Cliff and the Future of Generics in Asia : Trends that will Impact the Market in the Short Term

Patent Cliff and the Future of Generics in Asia : Trends that will Impact the Market in the Short Term

  • $ 3 500
  • Industry report
  • December 2014
  • by Frost & Sullivan

Executive Summary •The generic drug manufacturers in Asia have started looking beyond patent cliff to drive growth. As less drugs are expected to go off patent in 2015-2017, the manufacturers are adopting ...

  • Industries : Generic Drug
2015 Market Research Report on Global Biologics and Biosimilars Industry

2015 Market Research Report on Global Biologics and Biosimilars Industry

  • $ 2 600
  • Industry report
  • February 2015
  • by QY Research Group

Summary 2015 Market Research Report on Global Biologics and Biosimilars Industryis a professional and depth research report on Global Biologics and Biosimilars industry For overview analysis, the report ...

  • Industries : Generic Drug
  • Countries : World, China
The Generic Drugs Market: 2015 - 2030 - Opportunities, Challenges, Strategies & Forecasts

The Generic Drugs Market: 2015 - 2030 - Opportunities, Challenges, Strategies & Forecasts

  • $ 2 500
  • Industry report
  • February 2015
  • by SNS Telecom

A generic drug is a pharmaceutical product, usually intended to be interchangeable with an innovator product, that is manufactured without a license from the innovator company and marketed after the expiry ...

  • Industries : Generic Drug
  • Countries : World, Europe, Japan, South Korea, India, Asia, United States, North America, Canada, China, Africa, Netherlands, Saudi Arabia, South Africa
Generic Drugs Market in Japan 2015-2019

Generic Drugs Market in Japan 2015-2019

  • $ 2 500
  • Industry report
  • February 2015
  • by Infiniti Research Limited

About Generic Drugs A generic drug is a duplicate of brand-name drugs and has the same dosage form, active ingredient(s), potency, route of administration, quality, and intended use as that of branded ...

  • Industries : Generic Drug
  • Countries : Japan
Generics: World Market Overview (Market size, Segmentation and Trends Analysis)

Generics: World Market Overview (Market size, Segmentation and Trends Analysis)

  • $ 1 495
  • Industry report
  • December 2014
  • by MarketLine

It includes detailed data on industry size and sector ation, textual analysis of the key trends and competitive landscape, and profiles of the leading firms . This incisive report provides expert analysis ...

  • Industries : Generic Drug
  • Countries : World
Generic Pharmaceuticals Global - Industry Report

Generic Pharmaceuticals Global - Industry Report

  • $ 1 668
  • Industry report
  • January 2015
  • by Plimsoll Publishing Ltd UK

Plimsoll's GENERIC PHARMACEUTICALS (Global) analysis is the most definitive and accurate study of the GENERIC PHARMACEUTICALS (Global) sector in 2013. The report is split into two sections and uses both ...

  • Industries : Generic Drug
  • Countries : World
Serbia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Serbia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

BMI View: Despite a downgrade in our economic outlook for Serbia, BMI's expenditure projections for the pharmaceutical industry for from 2012 to 2015 are up moderately due to revisions to our previous ...

  • Industries : Generic Drug
  • Countries : Serbia and Montenegro
Mexico Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Mexico Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

BMI View: Despite our generally positive outlook for much of Latin America in 2012, we maintain the view that mounting fiscal pressures and a faltering business environment will damage Mexico’s attractiveness ...

  • Industries : Generic Drug
  • Countries : Mexico
Philippines Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Philippines Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

BMI View: Despite the government's commitment to providing affordable medical treatment for the population, the vast majority of people continue to have poor access to adequate healthcare. This is primarily ...

  • Industries : Generic Drug
  • Countries : Philippines
US Generic Drug Market Outlook 2018

US Generic Drug Market Outlook 2018

  • $ 1 200
  • Industry report
  • February 2015
  • by RNCOS

The US is the largest pharmaceutical market in the world. Driven by the factors such as large healthcare spending, high per-capita income, and strong research & development investments, the pharmaceutical ...

  • Industries : Generic Drug
  • Countries : United States
World Generic Markets 05 JANUARY 2015

World Generic Markets 05 JANUARY 2015

  • $ 1 114
  • Industry report
  • January 2015
  • by Espicom Business Intelligence

Industry Trend Analysis - National And International Legislation To Mould Generic Industry In 2015 Industry Brief - Teva Launches Erlotinib In Canada Industry Brief - Par Adds Name To Trokendi XR Patent ...

  • Industries : Generic Drug
  • Countries : World, United States
Generic Pharmaceutical Manufacturing Market in the United States

Generic Pharmaceutical Manufacturing Market in the United States

  • $ 1 020
  • Industry report
  • December 2014
  • by Ibisworld

IBISWORLD INDUSTRY RISK RATINGS REPORT This is the replacement for IBISWorld's March Generic Pharmaceutical Manufacturing in the US Industry Risk Ratings Report. Industry Risk Ratings Synopsis This Industry ...

  • Industries : Generic Drug
  • Countries : United States
Brazil Pharmaceutical Market Outlook 2018

Brazil Pharmaceutical Market Outlook 2018

  • $ 1 000
  • Industry report
  • December 2014
  • by RNCOS

Brazil is considered as one of the most lucrative healthcare markets, accounting for the highest healthcare expenditure in Latin America. It is the largest pharmaceutical market in Latin America and the ...

  • Industries : Generic Drug
  • Countries : Brazil
Fesoterodine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Fesoterodine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Frovatriptan  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Frovatriptan - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Galantamine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Galantamine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Ibandronic Acid  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Ibandronic Acid - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Imatinib  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Imatinib - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Lasofoxifene  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Lasofoxifene - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Pitavastatin  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Pitavastatin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Prasugrel  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Prasugrel - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Rizatriptan  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Rizatriptan - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Valganciclovir  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Valganciclovir - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Eletriptan  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Eletriptan - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Losartan  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Losartan - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Tamsulosin  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Tamsulosin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Tolterodine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Tolterodine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Zoledronic Acid  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Zoledronic Acid - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Zolmitriptan  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Zolmitriptan - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Febuxostat  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Febuxostat - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World

7 Companies

Read our Company Profiles

Mylan Inc.

United States

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

Teva Pharmaceuticals

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.